This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
ESMO GI
Presentations

Ladiratuzumab vedotin | Gastrointestinal Cancer | Abstract P-228
SGNLVA-005: Open-Label, Phase 2 Study of Ladiratuzumab Vedotin (LV) for Advanced Aerodigestive Tract Malignancies (Trial in Progress)